• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[妇科肿瘤中的血清核糖核酸酶活性。细胞抑制疗法下卵巢癌血清核糖核酸酶的表现]

[Serum ribonuclease activity in gynecologic neoplasms. The behavior of serum ribonuclease in ovarian cancer under cytostatic therapy].

作者信息

Schleich H G, Wiest W

出版信息

Fortschr Med. 1980 Sep 25;98(36):1384-6.

PMID:7461546
Abstract

Ribonuclease activity in the serum of patients with histologically confirmed ovarian carcinoma is significantly higher than in serum of patients with benign tumors of the ovary and that of healthy controls. In 847 samples collected during a period of 20 months the course of the ribonuclease activity of 41 patients receiving cytostatic treatment was determined. The ovarian carcinoma of all 41 patients was histologically ascertained. Three typical examples are presented.

摘要

经组织学确诊的卵巢癌患者血清中的核糖核酸酶活性显著高于卵巢良性肿瘤患者及健康对照者的血清。在20个月内收集的847份样本中,测定了41例接受细胞抑制治疗患者的核糖核酸酶活性变化过程。所有41例患者的卵巢癌均经组织学确诊。现给出三个典型病例。

相似文献

1
[Serum ribonuclease activity in gynecologic neoplasms. The behavior of serum ribonuclease in ovarian cancer under cytostatic therapy].[妇科肿瘤中的血清核糖核酸酶活性。细胞抑制疗法下卵巢癌血清核糖核酸酶的表现]
Fortschr Med. 1980 Sep 25;98(36):1384-6.
2
[Serum ribonuclease in patients with malignant tumor of the ovary].[卵巢恶性肿瘤患者的血清核糖核酸酶]
Zhonghua Fu Chan Ke Za Zhi. 1991 Jan;26(1):17-20, 61.
3
[Serum ribonuclease activity in patients with gynaecologic malignomas (author's transl)].妇科恶性肿瘤患者的血清核糖核酸酶活性(作者译)
Geburtshilfe Frauenheilkd. 1979 Nov;39(11):940-6.
4
[Determination of the plasma ribonuclease activity as a diagnostic aid in the diagnosis of ovarian cancer. Results of a double blind study (author's transl)].[测定血浆核糖核酸酶活性作为卵巢癌诊断辅助手段。一项双盲研究的结果(作者译)]
Geburtshilfe Frauenheilkd. 1979 Jun;39(6):497-502.
5
Serum ribonuclease activity in patients with ovarian tumors.卵巢肿瘤患者的血清核糖核酸酶活性
Eur J Gynaecol Oncol. 1986;7(2):76-81.
6
Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.二氢二醇脱氢酶的过表达与卵巢癌患者基于顺铂的化疗耐药相关。
Gynecol Oncol. 2005 Apr;97(1):110-7. doi: 10.1016/j.ygyno.2004.12.031.
7
Serum enzymes in ovarian carcinoma.卵巢癌中的血清酶
Neoplasma. 1979;26(6):737-43.
8
[Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].[基质金属蛋白酶-9及纤连蛋白在复发性上皮性卵巢癌中的表达升高]
Orv Hetil. 2004 Aug 1;145(31):1617-24.
9
[Alterations of the plasma ribonuclease activity in female wistar rats under the conditions of combined therapy of the ovary carcinoma (author's transl)].卵巢癌联合治疗条件下雌性Wistar大鼠血浆核糖核酸酶活性的改变(作者译)
Strahlentherapie. 1979 Dec;155(12):864-8.
10
[Changes of plasma ribonuclease activities according to the method of treatment in gynecologic cancer patients (author's transl)].妇科癌症患者血浆核糖核酸酶活性随治疗方法的变化(作者译)
Nihon Sanka Fujinka Gakkai Zasshi. 1981 Oct;33(10):1749-56.

引用本文的文献

1
Increasing human serum ribonuclease activity is a concomitant phenomenon of ovarian carcinoma.人血清核糖核酸酶活性增加是卵巢癌的一个伴随现象。
J Cancer Res Clin Oncol. 1980;97(3):307-14. doi: 10.1007/BF00405783.